Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa
NCT00494351 · View on ClinicalTrials.gov ↗
Study Summary
* Determination of the short and long term efficacy of NdYag laser for treatment of Hidradenitis suppurativa, which is an inflamed, deeper follicular disorders. * Determination of patient tolerance of discomfort associated with NdYag laser treatment for Hidradenitis suppurativa. * Determination of the impact of this condition on quality of life and if there is any impact of therapy in the dermatology quality of life index. * Evaluate the histopathologic changes of YAG therapy on affected skin Second phase of study: * Prospective, controlled clinical and histologic study of patients with Hurley Stage II HS disease. * 19 patients of skin types II to VI with Hurley Stage II hidradenitis suppurativa lesions of the axilla and groin. This is a different set of patients than those treated in the first phase of the study above. This study primarily focuses on and further characterizes the histologic changes after laser treatment.
Conditions Studied
Interventions
- PROCEDURE Long-pulsed Nd:YAG laser 1064 nm
Study Locations (1)
Michigan
- Department of Dermatology, Henry Ford Medical Center, 3031 West Grand Boulevard, — Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-06 |
| Est. Completion | 2009-07 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00494351
The ClinicalTrials.gov registry entry for NCT00494351 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 171 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Hidradenitis Suppurativa appearing as the primary indexed condition, and to 1 intervention — of which Long-pulsed Nd:YAG laser 1064 nm is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT00494351 reports 1 study location spanning 1 distinct geographic area — top geographies include Michigan. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT00494351 about?
NCT00494351 is a clinical study titled "Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa". * Determination of the short and long term efficacy of NdYag laser for treatment of Hidradenitis suppurativa, which is an inflamed, deeper follicular disorders. * Determination of patient tolerance of discomfort associated with NdYag laser treatment for Hidradenitis suppurativa. * Determination of t...
What is the current status of trial NCT00494351?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2007-06. Estimated completion is 2009-07.
What conditions does trial NCT00494351 study?
This clinical trial studies the following conditions: Hidradenitis Suppurativa. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT00494351?
The interventions under investigation include: Long-pulsed Nd:YAG laser 1064 nm (PROCEDURE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT00494351?
This trial is sponsored by Henry Ford Health System, which has 171 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT00494351 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.